David H. Bollinger

Array ( [id] => 5889592 [patent_doc_number] => 20020013458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Enzymatic nucleic acid treatment of disases or conditions related to hepatitis c virus infection' [patent_app_type] => new [patent_app_number] => 09/504231 [patent_app_country] => US [patent_app_date] => 2000-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 42271 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013458.pdf [firstpage_image] =>[orig_patent_app_number] => 09504231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4308295 [patent_doc_number] => 06316197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes' [patent_app_type] => 1 [patent_app_number] => 9/495724 [patent_app_country] => US [patent_app_date] => 2000-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 44 [patent_no_of_words] => 15308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316197.pdf [firstpage_image] =>[orig_patent_app_number] => 495724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4362828 [patent_doc_number] => 06287556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Intracellular delivery vehicles' [patent_app_type] => 1 [patent_app_number] => 9/469197 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9497 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287556.pdf [firstpage_image] =>[orig_patent_app_number] => 469197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1212511 [patent_doc_number] => 06709855 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-23 [patent_title] => 'Methods for detection and use of differentially expressed genes in disease states' [patent_app_type] => B1 [patent_app_number] => 09/461912 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 75 [patent_no_of_words] => 55540 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/709/06709855.pdf [firstpage_image] =>[orig_patent_app_number] => 09461912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446348 [patent_doc_number] => 06368800 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Kits for isolating biological target materials using silica magnetic particles' [patent_app_type] => B1 [patent_app_number] => 09/459502 [patent_app_country] => US [patent_app_date] => 1999-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 12958 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368800.pdf [firstpage_image] =>[orig_patent_app_number] => 09459502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409649 [patent_doc_number] => 06310048 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Antisense modulation of amyloid beta protein expression' [patent_app_type] => 1 [patent_app_number] => 9/458481 [patent_app_country] => US [patent_app_date] => 1999-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18418 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310048.pdf [firstpage_image] =>[orig_patent_app_number] => 458481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357728 [patent_doc_number] => 06576759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-10 [patent_title] => 'Antisense inhibition of RAD51' [patent_app_type] => B2 [patent_app_number] => 09/454495 [patent_app_country] => US [patent_app_date] => 1999-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 9747 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576759.pdf [firstpage_image] =>[orig_patent_app_number] => 09454495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4155221 [patent_doc_number] => 06156571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Antisense inhibition of SRC-3 expression' [patent_app_type] => 1 [patent_app_number] => 9/440612 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28798 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156571.pdf [firstpage_image] =>[orig_patent_app_number] => 440612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068798 [patent_doc_number] => 06844324 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-18 [patent_title] => 'Modular peptide mediated intracellular delivery system and uses therefore' [patent_app_type] => utility [patent_app_number] => 09/438905 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 11 [patent_no_of_words] => 9800 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844324.pdf [firstpage_image] =>[orig_patent_app_number] => 09438905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202509 [patent_doc_number] => 06720154 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Purified stat proteins and methods of purifying thereof' [patent_app_type] => B1 [patent_app_number] => 09/430806 [patent_app_country] => US [patent_app_date] => 1999-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 7 [patent_no_of_words] => 31967 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720154.pdf [firstpage_image] =>[orig_patent_app_number] => 09430806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4291168 [patent_doc_number] => 06180403 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression' [patent_app_type] => 1 [patent_app_number] => 9/429093 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15079 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180403.pdf [firstpage_image] =>[orig_patent_app_number] => 429093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4245108 [patent_doc_number] => 06136604 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Antisense inhibition of methionine aminopeptidase 2 expression' [patent_app_type] => 1 [patent_app_number] => 9/428584 [patent_app_country] => US [patent_app_date] => 1999-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28041 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136604.pdf [firstpage_image] =>[orig_patent_app_number] => 428584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355683 [patent_doc_number] => 06190869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Antisense inhibition of protein kinase C-theta expression' [patent_app_type] => 1 [patent_app_number] => 9/429322 [patent_app_country] => US [patent_app_date] => 1999-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23673 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190869.pdf [firstpage_image] =>[orig_patent_app_number] => 429322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4168170 [patent_doc_number] => 06140125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Antisense inhibition of bcl-6 expression' [patent_app_type] => 1 [patent_app_number] => 9/418640 [patent_app_country] => US [patent_app_date] => 1999-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28744 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140125.pdf [firstpage_image] =>[orig_patent_app_number] => 418640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151435 [patent_doc_number] => 06124133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Antisense inhibition of fra-1 expression' [patent_app_type] => 1 [patent_app_number] => 9/418641 [patent_app_country] => US [patent_app_date] => 1999-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27766 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124133.pdf [firstpage_image] =>[orig_patent_app_number] => 418641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361519 [patent_doc_number] => 06169176 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Deoxynucleic alkyl thiourea compounds and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/407675 [patent_app_country] => US [patent_app_date] => 1999-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 50 [patent_no_of_words] => 19172 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169176.pdf [firstpage_image] =>[orig_patent_app_number] => 407675 [rel_patent_id] =>[rel_patent_doc_number] =>)